156 related articles for article (PubMed ID: 30245032)
1. Periprocedural Considerations for Anticoagulated Atrial Fibrillation Patients.
Collins-Yoder A; Collins RE
J Perianesth Nurs; 2019 Apr; 34(2):227-239. PubMed ID: 30245032
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy.
Oprea AD; Noto CJ; Halaszynski TM
J Clin Anesth; 2016 Nov; 34():586-99. PubMed ID: 27687455
[TBL] [Abstract][Full Text] [Related]
4. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants.
Healey JS; Brambatti M
Can J Cardiol; 2013 Jul; 29(7 Suppl):S54-9. PubMed ID: 23790599
[TBL] [Abstract][Full Text] [Related]
6. Updates in periprocedural management of direct oral anticoagulants.
Tao J; Oprea AD
Curr Opin Anaesthesiol; 2020 Jun; 33(3):423-431. PubMed ID: 32371643
[TBL] [Abstract][Full Text] [Related]
7. Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.
Ibrahim A; Walsh LG; Algaali M; Satti Z; Kiernan TJ; Yan BP
Expert Opin Pharmacother; 2019 Mar; 20(4):465-472. PubMed ID: 30521411
[TBL] [Abstract][Full Text] [Related]
8. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
Am J Med; 2018 May; 131(5):574.e13-574.e27. PubMed ID: 29274754
[TBL] [Abstract][Full Text] [Related]
9. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
10. Managing the perioperative patient on direct oral anticoagulants.
Leitch J; van Vlymen J
Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
[TBL] [Abstract][Full Text] [Related]
11. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
Senoo K; Lip GY
Int J Cardiol; 2016 Oct; 221():379-82. PubMed ID: 27409565
[TBL] [Abstract][Full Text] [Related]
12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
13. Should HAS-BLED scoring be revised for better risk estimation in patients with intracerebral hemorrhage?
Ince B; Benbir G; Gozubatik-Celik G
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):929-31. PubMed ID: 25017498
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
[TBL] [Abstract][Full Text] [Related]
15. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.
Deitelzweig S; Farmer C; Luo X; Li X; Vo L; Mardekian J; Fahrbach K; Ashaye A
Curr Med Res Opin; 2018 Mar; 34(3):487-498. PubMed ID: 29188721
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
Trujillo TC; Dobesh PP; Crossley GH; Finks SW
Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation and new therapeutic options in atrial fibrillation].
Mischke K
Dtsch Med Wochenschr; 2016 Oct; 141(22):1618-1623. PubMed ID: 27824417
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
Gray MP; Saba S; Zhang Y; Hernandez I
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural Anticoagulation Management For Nonoperating Room Anesthesia Procedures: A Clinical Guide.
Tao J; Oprea AD
Semin Cardiothorac Vasc Anesth; 2019 Dec; 23(4):352-368. PubMed ID: 31431127
[TBL] [Abstract][Full Text] [Related]
20. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]